" class="no-js "lang="en-US"> Gavi - Medtech Alert
Thursday, March 28, 2024
Gavi | Pharmtech Focus

Gavi

About Gavi

Gavi

Gavi, the Vaccine Alliance, helps vaccinate half the world’s children against deadly and debilitating infectious diseases. We are committed to working with our partners to #ProtectTheNextGeneration and realise our mission to save lives, reduce poverty and protect the world against the threat of epidemics.

Gavi, the Vaccine Alliance, brings together the public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the poorest countries. Since its inception in 2000, Gavi has helped prevent more than nine million deaths in developing countries and contributed to the immunisation of nearly 640 million children.

Related Story

Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s COVID-19 Vaccine for Low Income Countries in First Half of 2022

October 14 2021

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility

May 6 2021

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]